Streetbeat News

Price Targets

FATE

BMO Capital analyst Etzer Darout has maintained a 'Market Perform' rating on Fate Therapeutics (NASDAQ:FATE) and raised the price target from $5.4 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:12 pm

METC

BMO Capital analyst David Gagliano has maintained a 'Market Perform' rating on Ramaco Resources (NASDAQ:METC) and raised the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:09 pm

SCTL

RBC Capital analyst Sean Dodge maintains an 'Outperform' rating on Societal CDMO (NASDAQ:SCTL) but lowers the price target from $2 to $1.25.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:04 pm

SGHT

Morgan Stanley has maintained an Equal-Weight rating on Sight Sciences' stock but has lowered its price target from $4 to $3. This has led to a decrease in the trading price of Sight Sciences' shares.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:02 pm

PTEN

RBC Capital analyst Keith Mackey has maintained an 'Outperform' rating on Patterson-UTI Energy (NASDAQ:PTEN), but lowered the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:01 pm

DOOR

RBC Capital analyst Michael Dahl has maintained a 'Sector Perform' rating on Masonite International (NYSE:DOOR) but lowered the price target from $106 to $87.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:59 pm

MGNI

RBC Capital analyst Matthew Hedberg maintains an 'Outperform' rating on Magnite (NASDAQ:MGNI), but has lowered the price target from $15 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:58 pm

JAZZ

RBC Capital analyst Gregory Renza has maintained an 'Outperform' rating on Jazz Pharmaceuticals (NASDAQ:JAZZ), but lowered the price target from $200 to $191.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:56 pm

JAMF

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on Jamf Holding (NASDAQ:JAMF) but lowers the price target from $24 to $22.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:54 pm

JKHY

RBC Capital analyst Daniel Perlin has maintained a 'Sector Perform' rating on Jack Henry & Associates (NASDAQ:JKHY) and lowered the price target from $181 to $161.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:53 pm